Recerca > Càncer

Patologia oncològica

Nombre de publicacions
557
Cercador de publicacions

  • Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomic S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X

    Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.

    VIRCHOWS ARCHIV 478 851-863. .

    [doi:10.1007/s00428-020-02962-x]

  • Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B

    Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.

    Modern Pathology 34 994-1007. .

    [doi:10.1038/s41379-020-00721-6]

  • Vieites, B; Lopez-Garcia, MA; Martin-Salvago, MD; Ramirez-Tortosa, CL; Rezola, R; de Salas, MS; Vilaro, LL; Villellas, FV; Burgues, O; Fernandez-Rodriguez, B; Galan, LA; Peg, V

    Patient follow-up of NEOVATTL study

    ANNALS OF ONCOLOGY 32 49-49. .

    [doi:10.1016/j.annonc.2021.03.079]

  • Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI

    Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

    BREAST 56 52-53. .

  • Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Arozarena, I; Guerrero-Setas, D; Zudaire, T; Guarch, R; Vidal, A; Salas, JS; Matias-Guiu, X; Ausin, K; Gil, C; Hernandez-Alcoceba, R; Martin-Sanchez, E

    Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix

    Cancers 13 -. .

    [doi:10.3390/cancers13071739]

  • Archilla, I; Diaz-Mercedes, S; Aguirre, JJ; Tarragona, J; Machado, I; Rodrigo, MT; Lopez-Prades, S; Gorostiaga, I; Landolfi, S; Alen, BO; Balaguer, F; Castells, A; Camps, J; Cuatrecasas, M

    Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?

    Clinical and Translational Gastroenterology 12 -. .

    [doi:10.14309/ctg.0000000000000303]

  • Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium

    The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.

    HUMAN PATHOLOGY 109 80-91. .

    [doi:10.1016/j.humpath.2020.12.003]

  • Morales Murillo, Serafin; Gasol Cudos, Ariadna; Veas Rodriguez, Joel; Canosa Morales, Carles; Melé Olivé, Jordi; Vilardell Villellas, Felip; Sanchez Guzman, Douglas Rene; Iglesias Martínez, Edelmiro; Salud Salvia, Antonieta

    Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer

    BREAST 56 35-41. .

    [doi:10.1016/j.breast.2021.01.001]

  • Concin N; Matias-Guiu X; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann J; Bosse T; Chargari C; Fagotti A; Fotopoulou C; Martin AG; Lax S; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell D; Querleu D; Raspollini MR; Sehouli J; Sturdza A; Taylor A; Westermann A; Wimberger P; Colombo N; Planchamp F; Creutzberg CL

    ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

    RADIOTHERAPY AND ONCOLOGY 154 327-353. .

    [doi:10.1016/j.radonc.2020.11.018]

  • Bosse, T; Lax, S; Abu-Rustum, N; Matias-Guiu, X

    The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 40 102-110. .

    [doi:10.1097/PGP.0000000000000755]

  • Murillo, SM; Cudos, AG; Rodriguez, JV; Morales, CC; Olive, JM; Villellas, FV; Guzman, DRS; Martinez, EI; Salvia, AS

    Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

    Future Science Oa 7 -. .

    [doi:10.2144/fsoa-2020-0146]

  • Concin N; Creutzberg CL; Vergote I; Cibula D; Mirza MR; Marnitz S; Ledermann JA; Bosse T; Chargari C; Fagotti A; Fotopoulou C; González-Martín A; Lax SF; Lorusso D; Marth C; Morice P; Nout RA; O'Donnell DE; Querleu D; Raspollini MR; Sehouli J; Sturdza AE; Taylor A; Westermann AM; Wimberger P; Colombo N; Planchamp F; Matias-Guiu X

    ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma.

    VIRCHOWS ARCHIV 478 153-190. .

    [doi:10.1007/s00428-020-03007-z]